GENNIEFY
Market News
Latest financial news and analysis from global markets
NVDA
Archer Aviation Is Still Under $7. Here's Whether Long-Term Investors Should Pounce.
Archer Aviation trades at half the value of Joby, but the gap between the two is narrowing. Should you buy while it's still trading under $7?
INTC
Archer Aviation Is Still Under $7. Here's Whether Long-Term Investors Should Pounce.
Archer Aviation trades at half the value of Joby, but the gap between the two is narrowing. Should you buy while it's still trading under $7?
GOOGL
1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $5,000 and Hold for the Long Term
Alphabet's vast cash position and profits give the company a lot of time to test out ventures and see them to completion.
GOOGL
AI is boosting output rather than cutting jobs: analyst
Investing.com -- The rapid integration of Artificial Intelligence into the U.S. workforce has long sparked fears of mass job displacement. However, new research from Morgan Stanley suggests a more constructive reality: AI is currently acting as a catalyst for growth rather than a replacement for human capital.
MSFT
AI is boosting output rather than cutting jobs: analyst
Investing.com -- The rapid integration of Artificial Intelligence into the U.S. workforce has long sparked fears of mass job displacement. However, new research from Morgan Stanley suggests a more constructive reality: AI is currently acting as a catalyst for growth rather than a replacement for human capital.
NKE
Q2 catalyst: Will World Cup innovation deliver the rebound Nike and Adidas need?
Investing.com -- As the 2026 World Cup approaches, retail giants Nike (NYSE:NKE) and Adidas (OTC:ADDYY) are ramping up their offensive, aiming to capitalize on a tournament expected to inject significant energy into the global sportswear category.
TDOC
A Look At Teladoc Health (TDOC) Valuation As Earnings Uncertainty And EPS Pressure Stir Investor Caution
Why Teladoc Health (TDOC) Is Back in Focus Before Earnings Teladoc Health (TDOC) is drawing renewed attention as an upcoming earnings report, paired with projected earnings per share pressure and a cautious hold consensus, contributes to recent stock volatility and investor hesitation. See our latest analysis for Teladoc Health. Recent trading reflects this tension, with a 1 month share price return of 11.87% and a year to date share price return of negative 18.44%, while the 5 year total...
SO
How Investors May Respond To Southern (SO) Extending Its 25-Year Dividend Growth Streak
Earlier in April, Southern Company announced it is raising its regular quarterly dividend to US$0.76 per share, payable June 8, 2026, lifting its annualized payout to US$3.04. This increase marks the utility’s 25th consecutive year of higher dividends, underscoring a long-running emphasis on consistent cash returns to shareholders. We’ll now examine how this 25-year dividend growth streak shapes Southern’s investment narrative and what it may mean for income-focused investors. Rare earth...
PYPL
Is PayPal’s New NFL Peer‑to‑Peer Deal Reshaping The Investment Case For PayPal Holdings (PYPL)?
In April 2026, PayPal Holdings announced a new partnership making it the NFL’s official peer-to-peer payments partner, integrating its app across the league’s ecosystem and offering fans features like instant money transfers and access to sweepstakes for tickets and exclusive experiences. This deal, combined with Michael Burry’s recently disclosed increased position in PayPal, has sharpened investor focus on how the company’s peer-to-peer capabilities and broader payments platform fit into...
AMGN
Zai Lab Showcases 54% Brain Metastases Response for ZL-1310 ADC in SCLC at AACR Investor Call
Zai Lab (NASDAQ:ZLAB) hosted an investor call tied to the 2026 American Association for Cancer Research (AACR) meeting to highlight new data for its DLL3-targeted antibody-drug conjugate (ADC) zocilurtatug pelitecan (zoci; ZL-1310) in small cell lung cancer (SCLC) with brain metastases and in extrap
NVDA
The Mistakes I Keep Seeing ETF Investors Make With "Set It and Forget It" Funds
Long-term buy-and-hold doesn't mean ignoring your portfolio altogether. Avoid this and other common pitfalls to maximize your portfolio's potential.
INTC
The Mistakes I Keep Seeing ETF Investors Make With "Set It and Forget It" Funds
Long-term buy-and-hold doesn't mean ignoring your portfolio altogether. Avoid this and other common pitfalls to maximize your portfolio's potential.